Core Viewpoint - The article emphasizes the importance of investing in safe-haven assets and undervalued dividend-paying consumer staples stocks during periods of market volatility and geopolitical tension [1][2]. Group 1: Investment Strategy - Safe-haven assets like gold, silver, and U.S. Treasuries are recommended for hedging risks, although their effectiveness may vary [1]. - Consumer staples and utilities are considered safe investments due to their inelastic demand and established history of returning capital to shareholders [2]. Group 2: Selected Companies - **United Breweries Co. (CCU)**: - Benzinga Edge Value Score of 98.14, with a current dividend yield of 2.8% and a dividend payout ratio (DPR) of 58.9% [4]. - The stock trades at 16 times earnings and 0.85 times sales, showing positive price action [4]. - CCU shares have increased over 11% recently, with bullish indicators such as a Golden Cross and favorable MACD signals [7]. - **NuSkin Enterprises Inc. (NUS)**: - Benzinga Edge Value Score of 86.96, with a market cap of $540 million and a dividend yield of 2.08% [8]. - The company reduced its dividend payout from $0.39 to $0.06, but the current payout allows for future increases [8]. - NUS shares have risen 15% at the start of the year, indicating bullish momentum [11]. - **Cresud SACIF y A (CRESY)**: - Benzinga Edge Value Score of 93.82, with a dividend yield of over 5% and a DPR of 23.4% [12]. - The company operates in agriculture and real estate, providing diversification during geopolitical tensions [12]. - CRESY shares have formed a Golden Cross, with the 50-day SMA acting as support [15]. - **Weis Markets Inc. (WMK)**: - Benzinga Edge Value Score of 89.87, with a market cap of $1.68 billion and a dividend yield of 2% [16]. - The DPR is 35.79%, allowing potential for future dividend increases [16]. - WMK shares have shown bullish signals, with a breakout above the 50-day SMA and an RSI indicating upward momentum [18]. - **Calavo Growers Inc. (CVGW)**: - Benzinga Edge Value Score of 80.91, with a dividend yield of 3.09% and a DPR of 72% [19]. - The company operates in the fresh produce sector, which is less affected by tariffs [19]. - CVGW shares have surged nearly 20% recently, breaking above key moving averages [21].

Merger Investigations - RAPT Therapeutics will be acquired by GlaxoSmithKline LLC for $58.00 per share, with an estimated aggregate equity value of $2.2 billion. The investigation focuses on whether the RAPT Board breached its fiduciary duties by failing to conduct a fair process and whether the deal provides fair value to shareholders [2] - Calavo Growers will be acquired by Mission Produce, Inc. for $27.00 per share, consisting of $14.85 in cash and 0.9790 shares of Mission for each share of Calavo, valuing Calavo at approximately $430 million. The investigation concerns potential breaches of fiduciary duties by the Calavo Board regarding the fairness of the deal [4] - Penumbra will be acquired by Boston Scientific Corporation in a cash and stock transaction valuing Penumbra at $374 per share, with an enterprise value of approximately $14.5 billion. The investigation examines whether the Penumbra Board failed to conduct a fair process and whether the deal consideration is fair [6] - FONAR Corporation will be acquired by FONAR, LLC and FONAR Acquisition Sub, Inc. for $19.00 per share in an all-cash transaction. The investigation looks into whether the FONAR Board breached its fiduciary duties by not ensuring a fair process and fair value for shareholders [8]

Financial Performance - Full Year 2025 net income from continuing operations increased by 191% to $20.0 million, with adjusted net income rising by 42% to $28.9 million[2][20] - Total net sales for Fiscal Year 2025 decreased to $648.4 million, down from $661.5 million, primarily due to a 4% decline in Fresh segment sales[8][17] - Adjusted EBITDA from continuing operations for Fiscal Year 2025 increased by 12% to $40.8 million, compared to $36.5 million in the prior year[8][20] - Gross profit for Fiscal Year 2025 was $63.7 million, representing 10% of net sales, compared to $67.8 million in the prior year[8][18] - Net sales for the three months ended October 31, 2025, were $124,681,000, a decrease of 26.6% compared to $169,959,000 for the same period in 2024[43] - Gross profit for the three months ended October 31, 2025, was $11,648,000, down 28.5% from $16,290,000 in the prior year[43] - Operating income for the twelve months ended October 31, 2025, increased to $19,611,000, compared to $16,723,000 in 2024, reflecting a 17.9% growth[43] - Net income attributable to Calavo Growers, Inc. for the three months ended October 31, 2025, was $3,817,000, compared to a loss of $139,000 in the same period last year[43] - Adjusted net income from continuing operations for the twelve months ended October 31, 2025, was $28,907,000, up from $20,360,000 in 2024, representing a 42.3% increase[47] - The net income attributable to Calavo Growers, Inc. for the twelve months ended October 31, 2025, was $19.796 million, a substantial increase from $6.796 million in 2024[49] Segment Performance - The Fresh segment experienced a 31% decrease in sales for Q4 2025, totaling $106.3 million, driven by a 19% decline in average price per carton[8][13] - The Prepared segment saw a 20% increase in sales for Q4 2025, reaching $18.4 million, attributed to an 11% increase in sales volume[8][13] Expenses and Costs - SG&A expenses for Fiscal Year 2025 decreased by 16% to $42.1 million, reflecting lower professional fees and reduced headcount-related costs[8][19] - The company incurred $1.105 million in professional fees related to Mexican tax matters for the three months ended October 31, 2025, compared to $0.233 million in 2024, reflecting a significant increase[50] - A charge of $1.801 million was recorded to resolve grower advance balances associated with a tomato program from previous fiscal years, which is not indicative of current operations[55] - Other costs outside the normal course of operations amounted to $1.008 million, primarily related to finance organization recruiting and legal settlement expenses[56] Cash Flow and Assets - Total current assets decreased to $149,426,000 as of October 31, 2025, from $158,579,000 in 2024, a decline of 5.8%[45] - Total liabilities decreased to $83,691,000 as of October 31, 2025, down from $99,343,000 in 2024, a reduction of 15.8%[45] - Cash and cash equivalents increased to $61,155,000 as of October 31, 2025, compared to $57,031,000 in 2024, an increase of 3.7%[45] Strategic Developments - The company announced a strategic combination with Mission Produce, Inc., where shareholders will receive $27.00 per share, consisting of $14.85 in cash and stock[7][9] - The merger is expected to create cost synergies of $25 million and provide shareholders with opportunities for value creation[9][10] - Calavo and Mission are seeking stockholder approvals for a proposed transaction, which may face risks including regulatory approvals and potential delays[27] - The integration of Calavo and Mission's businesses may incur higher costs and challenges than anticipated, affecting expected synergies[27] - Calavo and Mission plan to file a joint proxy statement with the SEC regarding the proposed transaction, urging investors to review the documents carefully[32] Market and Economic Conditions - The company anticipates softer first quarter results for 2026 due to continued strong avocado supply and pricing dynamics[12] - The companies are exposed to various risks such as economic conditions, client spending reductions, and changes in agricultural product prices[27] - The impact of macroeconomic trends, including increased interest rates, may affect borrowing costs and consumer behavior[29] - The companies are subject to enhanced regulatory scrutiny, which could lead to shipment delays and increased costs[29] - The companies are reliant on large customers and key personnel, which poses risks to their operational stability[28] Non-GAAP Measures - Non-GAAP measures such as adjusted EBITDA and adjusted net income are used to provide a clearer view of financial performance, excluding certain unusual items[37][38] - Adjusted EBITDA is calculated by excluding costs related to acquisitions, restructuring, and other one-time items, providing insight into ongoing operations[39] Foreign Currency Impact - The company reported a foreign currency gain of $4,291,000 for the three months ended October 31, 2025, compared to a loss of $3,041,000 in the same period last year[43] - Foreign currency remeasurement gains were $4.291 million for the three months ended October 31, 2025, compared to a loss of $3.041 million in the same period of 2024, indicating a positive shift in currency impact[52] Interest and Tariff Costs - Interest income rose to $(754) thousand for the three months ended October 31, 2025, from $(680) thousand in 2024, while interest expense decreased to $211 thousand from $274 thousand[49] - Costs related to tariffs for the three months ended October 31, 2025, were less than $0.1 million, primarily due to temporary tariffs on goods sourced from Mexico[53] - The company recorded $867 thousand in FDA regulatory hold-related charges for the three months ended October 31, 2025, reflecting unusual and non-recurring costs[54]

Core Viewpoint - The proposed sale of Calavo Growers, Inc. to Mission Produce, Inc. is under investigation to assess whether the offered consideration adequately values the company [1]. Group 1: Transaction Details - Shareholders of Calavo Growers will receive $14.85 in cash and 0.9790 shares of Mission Produce for each share of Calavo they own [1]. - The law firm Kahn Swick & Foti, LLC is examining the adequacy of the transaction and the process leading to it [1]. Group 2: Legal Rights and Contact Information - Individuals who believe the transaction undervalues Calavo Growers can contact Kahn Swick & Foti to discuss their legal rights without any obligation or cost [2]. - Contact details for Kahn Swick & Foti include a toll-free number and a website for further information [2].

Core Viewpoint - Monteverde & Associates PC is investigating Calavo Growers, Inc. regarding its merger with Mission Produce, Inc., questioning the fairness of the proposed transaction where Calavo shareholders would receive 0.9790 shares of Mission Produce and $14.85 in cash for each share of Calavo common stock [1] Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1] - The firm is located in the Empire State Building, New York City, and specializes in class action securities litigation [2] Group 2: Merger Details - Under the terms of the proposed merger, Calavo shareholders are expected to receive 0.9790 shares of Mission Produce common stock and $14.85 in cash for each share of Calavo common stock [1] - The investigation aims to determine if this deal is fair for Calavo shareholders [1]

Core Viewpoint - Mission Produce, Inc. is acquiring Calavo Growers, Inc. in a strategic move valued at $483 million, which is expected to reshape the avocado market landscape [1][2]. Group 1: Acquisition Details - The acquisition deal involves a cash-and-stock transaction where Calavo shareholders will receive $27 per share, consisting of $14.85 in cash and 0.97 shares of Mission for each Calavo share [2]. - The transaction is anticipated to close by the end of August 2026, with Mission shareholders expected to hold approximately 80.3% of the combined entity [2][6]. Group 2: Strategic Objectives - Mission Produce aims to expand its scale and diversify its product offerings through this acquisition, enhancing its supply chain across Mexico and California [3]. - The acquisition marks Mission's entry into the high-growth prepared food segment, complementing its existing avocado business [3]. Group 3: Expected Synergies and Value - The companies are targeting $25 million in synergies by the close of the transaction, with further cost synergies expected within 18 months post-close [4]. - This move will diversify Mission's portfolio across fresh produce, better serving customers and grower partners worldwide [4]. Group 4: Market Reaction - Despite the strategic nature of the acquisition, Mission Produce's stock price has decreased to $11.15, down 12.20% from its previous value [5][6]. - The stock has fluctuated between $10.37 and $11.75 during the day, with a market capitalization of approximately $787.4 million [5].

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Calavo Growers, Inc. to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission for each share of Calavo [1] Group 1: Investigation Details - The investigation focuses on whether Calavo and its board violated federal securities laws and/or breached fiduciary duties by not obtaining the best possible consideration for shareholders [2] - Concerns include whether Mission is underpaying for Calavo and if all material information necessary for shareholders to assess the merger consideration was disclosed [2] Group 2: Potential Actions - On behalf of Calavo shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, and other relief related to the proposed transaction [3] - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [3] Group 3: Firm Background - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]

Merger Investigations - Penumbra, Inc. is set to be acquired by Boston Scientific Corporation in a cash and stock transaction valuing Penumbra at $374 per share, with an enterprise value of approximately $14.5 billion. The investigation focuses on whether the Penumbra Board breached its fiduciary duties by failing to conduct a fair process and whether the deal provides fair value to shareholders [2] - Calavo Growers, Inc. will be acquired by Mission Produce, Inc., with Calavo stockholders receiving $27.00 per share, consisting of $14.85 in cash and 0.9790 shares of Mission for each share of Calavo. The total enterprise value of the transaction is approximately $430 million. The investigation examines if the Calavo Board breached its fiduciary duties regarding the fairness of the deal [4] - Clearwater Analytics Holdings, Inc. is being acquired by a Permira and Warburg Pincus-led Investor Group for $24.55 per share in cash, amounting to approximately $8.4 billion. The investigation looks into whether the Clearwater Analytics Board failed to conduct a fair process and if the deal consideration is fair for shareholders [6]

Core Viewpoint - The company's shares experienced a rise of up to 6.8% before slightly reducing gains, reflecting strong market interest and performance [1] Summary by Relevant Sections - Stock Performance - The stock has increased nearly 50% over the past year, indicating significant growth and investor confidence [1]

Core Viewpoint - Mission has announced a definitive agreement to acquire Calavo, indicating a strategic move to enhance its market position and operational capabilities [2]. Group 1: Acquisition Details - The acquisition of Calavo is expected to strengthen Mission's portfolio and expand its operational reach [2]. - A press release and presentation regarding the acquisition have been made available online under the Investor Relations section of both companies' websites [3]. Group 2: Forward-Looking Statements - The comments made during the call and the accompanying presentation include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995 [3][4]. - These forward-looking statements are based on management's current expectations and beliefs, along with various assumptions about future events [4].